Webinar Archive
The following webinars were carried out by The Binding Site Inc. To download or view any of these webinars, please click on the links below once you have registered with us or signed in below.
| Title | Author | Date | Time |
|---|---|---|---|
A Clinical Perspective of Serum Free Light Chain AnalysisObjectives of this hour-long program are to: Define the principle of the serum free light chain assay Describe the benefits of the serum free light chain assay versus current serum and urine analyses Identify the clinical applications and benefits of the serum free light chain assay in the management of monoclonal gammopathies Discuss patient cases demonstrating the usefulness of the serum free light chain analysis in clinical investigation. Please sign in or register to view this Webinar. | Donna E. Reece, M.D. Princess Margaret Hospital, Toronto, ON CANADA | 21/05/2008 | 53 minutes 51 seconds |
Diagnosis and Management of Multiple Myeloma and Other Monoclonal Gammopathies - CME credits provided (US only)Gain a clinical perspective on diagnostic tests and therapeutic advances for multiple myeloma, monoclonal gammopathy of unknown significance (MGUS) and amyloidosis. Objectives: At the end of the program, participants will be able to: 1 . Describe the latest clinical laboratory tests, cytogenetics, and staging systems used in the management of patients with multiple myeloma. 2. Describe the pitfalls in diagnosing and managing patients with multiple myeloma, MGUS and amyloidosis. Post test questions and a PDF of this presentation are available on the feedback page after viewing the webinar. Please sign in or register to view this Webinar. | Robert A. Vescio, M.D. Director, Multiple Myeloma and Bone Metastases Program, Comprehensive Cancer Center, Cedars-Sinai Medical Center Los Angeles, CA | 04/03/2008 | 1 hour 17 minutes 4 seconds |
Serum Free Light Chain Assays: Value in the Diagnosis of Paraproteinemic Renal DiseaseDr. Karen van Hoeven, Medical Director, The Binding Site Inc, discusses the appropriate use of blood tests for free kappa and free lambda light chains (Freelite™) and how they are interpreted. These assays were integrated into the 2006 diagnostic algorithm for multiple myeloma by the International Myeloma Working Group. Their application for the diagnosis of paraproteinemic renal disease is discussed in depth in this webinar, as it was at the NKF 2007 workshop. Please sign in or register to view this Webinar. | K.H. Van Hoeven Medical Director. The Binding Site Inc | 16/10/2007 | 48 minutes 30 seconds |
New Users
Please register your details with us if you have not sent an enquiry from this site before.
Existing Users
Please enter your registered email address and password.
